Insulin-like growth factor binding proteins: New proteins, new functions

Hormone Research

Volumn 51, Issue 2, 1999, Pages 53-67

  Ferry Jr , Robert J ^a   Cerri, Ruben W ^a   Cohen, Pinchas ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; IGF independent; Insulin like growth factor; Insulin like growth factor binding protein; Insulin like growth factor binding protein related protein; Prostate cancer

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN RECEPTOR;

BINDING AFFINITY; BODY GROWTH; CELL DIFFERENTIATION; CELL PROLIFERATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; SOMATOMEDINS;

EID: 0344655675     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023315     Document Type: Review

References (166)

1. Baxter RC: Insulin-like growth factor binding proteins in the human circulation, a review. Horm Res 1994;42:140-144.
2. Khosravi MJ, Diamandi A, Mistry J, Krishna RG, Khare A: Acid-labile subunit of human insulin-like growth factor-binding protein complex: Measurement, molecular, and clinical evaluation (comment in J Clin Endocrinol Metab 1997;82:3941-3943). J Clin Endocrinol Metab 1997;82:3944-3951.
3. Hasegawa T, Cohen P, Rosenfeld RG: Characterization of the insulin-like growth factor axis in TM 3 Leydig cells. Growth Regul 1995;5: 151-159.
4. Cohen P, Rosenfeld RG: The IGF axis; in Rosenbloom AL (ed): Human Growth Hormone, Basic and Scientific Aspects. Boca Raton, CRC Press, 1995, pp 43-58.
5. Arany E, Afford S, Strain AJ, Winwood PJ, Arthur MJ, Hill DJ: Differential cellular synthesis of insulin-like growth factor binding protein 1 and IGFBP-3 within human liver. J Clin Endocrinol Metab 1994;79:1871-1876.
6. Chin E, Zhou J, Dai J, Baxter RC, Bondy CA: Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology 1994;134:2498-2504.
7. Villafuerte BC, Koop BL, Pao CI, Gu L, Birdsong GG. Phillips LS: Coculture of primary rat hepatocytes and nonparenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro. Endocrinology 1994;134: 2044-2050.
8. Rosenfeld RG, Pham H, Cohen P, Fielder P, Gargosky SE, Müller H, Nonoshita L, Oh Y: Insulin-like growth factor binding proteins and their regulation. Acta Paediatr 1994;339 (suppl):154-158.
9. Baxter RC, Binoux MA, Clemmons DR, Conover CA, Drop SL, Holly JM, Mohan S, Oh Y, Rosenfeld RG: Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology 1998;139: 4036.
10. Cohen P, Fielder PJ, Hasegawa Y, Frisch H, Giudice LC, Rosenfeld RG: Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol 1991;124(suppl 2):74-85.
11. Holly JMP, Martin JL: IGFBPs: A review of methodological aspects of their purification, analysis and regulation. Growth Regul 1994; 4(suppl):20-30.
12. Lamson G, Giudice LC, Rosenfeld RG: Insulin-like growth factor binding proteins: Structural and molecular relationships. Growth Factors 1991;5:19-28.
13. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR: Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 1994;42:145-151.
14. Katz LEL, Rosenfeld RG, Cohen P: Clinical significance of insulin-like growth factor binding proteins (IGFBPs). Endocrinologist 1995;5: 36-43.
15. Smith WJ, Underwood LE, Clemmons DR: Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 1995;80:443-449.
16. Baxter RC, Saunders H: Radioimmunoassay of insulin-like growth factor-binding protein-6 in human serum and other body fluids. J Endocrinol 1992;134:133-139.
17. Mohan S, Farley JR, Baylink DJ: Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: Implications for bone loss with aging. Prog Growth Factor Res 1995; 6:465-473.
18. Mohan S, Libanati C, Dony C, Lang K, Srinivasan N, Baylink DJ: Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J Clin Endocrinol Metab 1995;80:2638-2645.
19. Shimasaki S, Ling N: Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog Growth Factor Res 1991;3:243-266.
20. Hong YS, Kim SY, Bhattacharya A, Pratt DR, Hong WK, Tainsky MA: Structure and function of the HOX A1 human homeobox gene cDNA. Gene 1995;159:209-214.
21. Matsui T, Hirai M, Hirano M, Kurosawa Y: The HOX complex neighbored by the EVX gene, as well as two other homeobox-containing genes, the GBX-class and the EN-class, are located on the same chromosomes 2 and 7 in humans. FEBS Lett 1993;336:107-110.
22. Allander SV, Bajalica S, Larsson C, Luthman H, Powell DR, Stern I, Weber G, Zazzi H, Ehrenborg E: Structure and chromosomal localization of human insulin-like growth factor-binding protein genes. Growth Regul 1993;3: 3-5.
23. Ruoslathi E, Pierschlaber MD: New perspectives in cell adhesions: RGD and integrins. Science 1987;238:491-497.
24. Coverley JA, Baxter RC: Phosphorylation of insulin-like growth factor binding proteins. Mol Cell Endocrinol 1997;128:1-5.
25. Levitt Katz LE, Satin-Smith MS, Collett-Solberg P, Thornton PS, Baker L, Stanley CA, Cohen P: Insulin-like growth factor binding protein-1 levels in the diagnosis of hypoglycemia caused by hyperinsulinism (comment in J Pediatr 1997;131:171-173). J Pediatr 1997; 131:193-199.
26. Counts DR, Gwirtsman H, Carlsson LM, Lesem M, Cutler GB Jr: The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab 1992;75:762-767.
27. Strasser-Vogel B, Blum WF, Past R, Kessler U, Hoeflich A, Meiler B, Kiess W: Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: Correlation with metabolic control and height attainment. J Clin Endocrinol Metab 1995;80:1207-1213.
28. Unterman TG, Oehler DT, Murphy LJ, Lacson RG: Multihormonal regulation of insulin-like growth factor-binding protein-1 in rat H4IIE hepatoma cells: The dominant role of insulin. Endocrinology 1991;128:2693-2701.
29. Argente J, Caballo N, Barrios V, Munoz MT, Pozo J, Chowen JA, Hernandez M: Disturbances in the growth hormone-insulin-like growth factor axis in children and adolescents with different eating disorders. Horm Res 1997;48(suppl 4):16-18.
30. Conover CA, Divertie GD, Lee PD: Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. Acta Endocrinol 1993;128:140-143.
31. Lee PDK, Conover CA, Powell DR: Regulation and function of insulin-like growth factor binding protein-1. Proc Soc Exp Biol Med 1993; 204:4-29.
32. Price WA, Stiles AD, Moats-Staats BM, D'Ercole AJ: Gene expression of insulin-like growth factors (IGFs), the type I IGF receptor, and the IGF-binding proteins in dexamethasone-induced fetal growth retardation. Endocrinology 1992;130:1424-1432.
33. Conover CA, Lee PD, Riggs BL, Powell DR: Insulin-like growth factor binding protein-1 expression in cultured human bone cells: Regulation by insulin and giucocorticoids. Endocrinology 1996;137:3295-3301.
34. Samstein B, Hoimes ML, Fan J, Frost RA, Gelato MC, Lang CH: IL-6 stimulation of insulin-like growth factors binding proteins (IGFBPs) production. Biochem Biophy Res Commun 1996;228:611-615.
35. Murphy LJ, Rajkumar K, Molnar P: Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice. Prog Growth Factor Res 1995;6:425-432.
36. Gutierrez-Ospina G, Calikoglu AS, Ye P, D'Ercole AJ: In vivo effects of insulin-like growth factor-I on the development of sensory pathways: Analysis of the primary somatic sensory cortex (S1) of transgenic mice. Endocrinology 1996;137:5484-5492.
37. Russo VC, Bach LA, Fosang AJ, Baker NL, Werther GA: Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Endocrinology 1997;138:4858-4867.
38. Arai T, Busby W Jr, Clemmons DR: Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology 1996; 137:4571-4575.
39. 4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis. Am J Physiol 1995;269:L151-L157.
40. Schwander J, Mary JL: The RIA for IGFBP-2 in man: A meagre catch? Growth Regul 1993;3: 104-108.
41. Bernardini S, Cianfarani S, Spagnoli A, Annicchiarico-Petruzzelli M, Melino G, Massoud R, Boscherini B, Finazzi-Agro A, Rosenfeld RG, Federici G: Expression and down-regulation by retinoic acid of IGF binding protein-2 and -4 in medium from human neuroblastoma cells. J Neuroendocrinol 1994;6:409-413.
42. Müller HL, Oh Y, Lehrnbecher T, Blum WF, Rosenfeld RG: Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab 1994;79:428-434.
43. Hardouin S, Gourmelen M, Noguiez P, Seurin D, Roghani M, Le Bouc Y, Povoa G, Merimee TJ, Hossenlopp P, Binoux M: Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: Relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab 1989;69:1291-1301.
44. Kelley KM, Oh Y, Gargosky SE, Gucef Z, Matsumoto T, Hwa I, Ng L, Simpson DM, Rosenfeld RG: Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 1996;28:619-637.
45. Sommer A, Spratt SK, Tatsuno GP, Tressel T, Lee R, Maack CA: Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3). Growth Regul 1993;3:46-49.
46. Paolisso G, Ammendola S, Del Buono A, Gambardella A, Riondino M, Tagliamonte MR, Rizzo MR, Carella C, Varricchio M: Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: Relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J Clin Endocrinol Metab 1997;82: 2204-2209.
47. Conover CA, Clarkson JT, Bale LK: Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts. Endocrinology 1995; 136:1403-1410.
48. Gucev ZS, Oh Y, Kelley KM, Labarta JI, Vorwerk P, Rosenfeld RG: Evidence for insulin-like growth factor (IGF)-independent transcriptional regulation of IGF binding protein-3 by growth hormone in SKHEP-1 human hepatocarcinoma cells. Endocrinology 1997;138: 1464-1470.
49. Vaccarello MA, Diamond FB Jr, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky S, Cohen P, Wilson K, Rosenfeld RG: Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/ Laron syndrome. J Clin Endocrinol Metab 1993;77:273-280.
50. Kanety H, Karasik A, Klinger B, Silbergeld A, Laron Z: Long-term treatment of Laron-type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity. Acta Endocrinol 1993;128:144-149.
51. Zapf J, Hauri C, Waldvogel M, Futo E, Hasler H, Binz K, Guler HP, Schmid C, Frocsch ER: Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc Natl Acad Sci USA 1989;86:3813-3817.
52. Lemmey AB, Glassford J, Flick-Smith HC, Holly JM, Pell JM: Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I. J Endocrinol 1997;154:319-328.
53. Conover CA, Clarkson JT, Durham SK, Bale LK: Cellular actions of insulin-like growth factor binding protein-3; in LeRoith D, Raizada MK (eds): Current Directions in Insulin-Like Growth Factor Research. New York, Plenum Press, 1994, pp 255-265.
54. Kanzaki S, Baxter RC, Knutsen R, Baylink DJ, Mohan S: Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions. J Bone Miner Res 1995;10:854-858.
55. Olney RC, Wilson DM, Mohtai M, Fielder PJ, Smith RL: Interleukin-1 and tumor necrosis factor-alpha increase insulin-like growth factor-binding protein-3 (IGFBP-3) production and IGFBP-3 protease activity in human articular chondrocytes. J Endocrinol 1995;146: 279-286.
56. Besset V, Le Magueresse-Battistoni B, Collette J, Benahmed M: Tumor necrosis factor-alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells. Endocrinology 1996;137:296-303.
57. Oh Y, Müller HL, Ng L, Rosenfeld RG: Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 1995;270: 13589-13592.
58. Han GR, Dohi DF, Lee HY, Rajah R, Walsh GL, Hong WK, Cohen P, Kurie JM: All-transretinoic acid increases transforming growth factor-beta-2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-alpha-dependent signaling pathway. J Biol Chem 1997;272:13711-13716.
59. Hayden JM, Strong DD, Baylink DJ, Powell DR, Sampath TK, Mohan S: Osteogenic protein-1 stimulates production of insulin-like growth factor binding protein-3 nuclear transcripts in human osteosarcoma cells. Endocrinology 1997;138:4240-4247.
60. Huynh H, Yang YF, Pollak M: Estradiol and anticstrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chcm 1996;271:1016-1021.
61. 2 up-regulates insulin-like growth factor binding protein-3 expression and synthesis in human articular chondrocytes by a c-AMP-independent pathway: Role of calcium and protein kinase A and C. J Cell Biochem 1996;63:320-333.
62. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995;377:646-649.
63. Jaques G, Noll K, Wegmann B, Witten S, Kogan E, Radulescu RT, Havcmann K: Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology 1997;138:1767-1770.
64. Murphy LJ, Molnar P, Lu X, Huang H: Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. J Mol Endocrinol 1995;15:293-303.
65. Nickerson T, Pollak M, Huynh H: Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4, and 5. Endocrinology 1998; 139:807-810.
66. Oh Y, Müller HL, Lamson G, Rosenfeld RG: Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 1993;268: 14964-14971.
67. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ: Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 1995;270:20424-20431.
68. 3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 1991;129:3139-3146.
69. Twigg SM, Baxter RC: Insulin-like growth lactor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit. J Biol Chem 1998;273:6074-6079.
70. Booth BA, Boes M, Andress DL, Dake BL, Kiefer MC, Maack C, Linhardt RJ, Bar K, Caldwell EE, Weiler J: IGFBP-3 and IGFBP-5 association with endothelial cells: Role of C-terminal heparin binding domain. Growth Regul 1995;5:1-17.
71. Jones JI, Gockerman A, Busby WH Jr, Camacho-Hubner C, Clemmons DR: Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I. J Cell Biol 1993;121:679-687.
72. Andress DL, Birnbaum RS: Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 1992; 267:22467-22472.
73. Canalis E, Gabbitas B: Skeletal growth factors regulate the synthesis of insulin-like growth factor binding protein-5 in bone cell cultures. J Biol Chem 1995;270:10771-10776.
74. Conover CA, Bale LK, Clarkson JT, Torring O: Regulation of insulin-like growth factor binding protein-5 messenger ribonucleic acid expression and protein availability in rat osteoblast-like cells. Endocrinology 1993;132:2525-2530.
75. Okazaki R, Riggs BL, Conover CA: Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells. Endocrinology 1994;134: 126-131
76. Duan C, Hawes SB, Prevette T, Clemmons DR: Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J Biol Chem 1996;271: 4280-4288.
77. Bach LA, Thotakura NR, Rechler MM: Human insulin-like growth factor binding protein-6 is O-glycosylated. Growth Regul 1993;3:59-62.
78. Claussen M, Buergisser D, Schuller AG, Matzner U, Braulke T: Regulation of insulin-like growth factor (IGF)-binding protein-6 and mannose 6-phosphate/IGF-II receptor expression in IGF-IL-overexpressing NIH 3T3 cells. Mol Endocrinol 1995;9:902-912.
79. Sheikh MS, Shao ZM, Hussain A, Clemmons DR, Chen JC, Roberts CT Jr. LeRoith D, Fontana JA: Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: Synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. J Cell Physiol 1993;155:556-567.
80. Zhou Y, Mohan S, Linkhart TA, Baylink DJ, Strong DD: Retinoic acid regulates insulin-like growth factor-binding protein expression in human osteoblast cells. Endocrinology 1996;137: 975-983.
81. Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG: Prostate-specific antigen is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 1992;75:1046-1053.
82. Rajah R, Bhala A, Nunn SE, Peehl DM, Cohen P: 7S nerve growth factor is an insulin-like growth factor binding protein protease. Endocrinology 1996;137:2676-2682.
83. Conover C, DeLeon DD: Acid activated insulin-like growth factor binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. J Biol Chem 1994;2691:7076-7080.
84. Conover C, Perry J. Tindall D: Endogenous cathepsin-D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J Clin Endocrinol Metab 1995;80:987-993.
85. Nunn S, Peehl DM, Cohen P: Acid-activated insulin-like growth factor binding protein protease activity of cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma. J Cell Physiol 1997;171:196-204.
86. Claussen M, Kubler B, Wendland M, Neifer K, Schmidt B, Zapf J, Braulke T: Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology 1997;138:3797-3803.
87. Fowlkes JL, Suzuki K, Nagase H, Thrailkill KM: Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: A role for matrix metalloproteinases. Endocrinology 1994;135:2810-2813.
88. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H: Matrix metalloproteinases degrade insulin-like growth factor binding protein-3 in dermal fibroblast cultures. J Biol Chem 1994;269:742-746.
89. Rajah R, Nachajon RV, Collins MH, Hakonarson H, Grunstein MM, Cohen P: Elevated levels of IGF-binding protein protease MMP-I in asthmatic airway smooth muscle. Am J Resp Cell Mol Biol 1999;20:199-208.
90. Angelloz-Nicoud P, Harel L, Binoux M: Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases. Growth Regul 1996;6:130-136.
91. Zheng B, Clarke JB, Busby WH, Duan C, Clemmons DR: Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin. Endocrinology 1998;139:1708-1714.
92. Bereket A, Wilson TA, Kolasa AJ, Fan J, Lang CH: Regulation of the insulin-like growth factor system by acute acidosis. Endocrinology 1996;137:2238-2245.
93. Cohen P, Peehl DM, Graves HC, Rosenfeld RG: Biological effects of prostate-specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 1994;142: 407-415.
94. Blat C, Villaudy J, Binoux M: In vivo proteolysis of serum IGFBP-3 results in increased availability of IGF to target cells. J Clin Invest 1994; 93:2286-2290.
95. Besnard N, Pisselet C, Zapf J, Hornebeck W, Monniaux D, Monget P: Proteolytic activity is involved in changes in intrafollicular insulin-like growth factor binding protein levels during growth and atresia of ovine ovarian follicles. Endocrinology 1996;137:1599-1607.
96. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA: Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab 1995;80:2282-2288.
97. Fowlkes JL, Thrailkill KM, George-Nascimento C, Rosenberg CK, Serra DM: Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs)-3, -5, and -6 inhibit IGFBP-4 degradation. Endocrinology 1997;138:2280-2285.
98. Donnelly MJ, Holly JM: The role of IGFBP-3 in the regulation of IGFBP-4 proteolysis. J Endocrinol 1996;149:R1-R7.
99. Salahifar H, Baxter RC, Martin JL: Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: Inhibition by IGFs does not require IGF-IGFBP interaction. Endocrinology 1997;138: 1683-1690.
100. Li YM, Schacher DH, Liu Q, Arkins S, Rebeiz N, McCusker RH Jr, Dantzer R, Kelley KW: Regulation of myeloid growth and differentiation by the insulin-like growth factor I receptor. Endocrinology 1997;138:362-368.
101. Karas M, Danilenko M, Fishman D, LeRoith D, Levy J, Sharoni Y: Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in Ishikawa endometrial cancer cells. J Biol Chem 1997;272:16514-16520.
102. Olney RC, Tsuchiya K, Wilson DM, Mohtai M. Maloney WJ, Schurman DJ, Smith RL: Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4. J Clin Endocrinol Metab 1996;81: 1096-1103.
103. Barreca A, Artini PG, Cesarone A, Arvigo M, D'Ambrogio G, Genazzani AR, Giordano G, Minuto F: Interrelationships between follicle-stimulating hormone and the growth hormone-insulin-like growth factor-IGF-binding proteins axes in human granulosa cells in culture. J Endocrinol Invest 1996;19:35-42.
104. de la Sota RL, Simmen FA, Diaz T, Thatcher WW: Insulin-like growth factor system in bovine first-wave dominant and subordinate follicles. Biol Reprod 1996;55:803-812.
105. Hasegawa Y, Hasegawa T, Fujii K, Konii H, Anzo M, Aso T, Koto S, Takada M, Tsuchiya Y: High ratios of free to total insulin-like growth factor-I in early infancy. J Clin Endocrinol Metab 1997;82:156-158.
106. Powell DR: Effects of renal failure on the growth hormone-insulin-like growth factor axis. J Pediatr 1997;131:S13-S16.
107. Mohseni-Zadeh S, Binoux M: Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: An alternative mechanism in the regulation of IGF action. Endocrinology 1997;138:5645-5648.
108. Noll K, Wegmann B, Havemann K, Jaques G: Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines. J Clin Endocrinol Metab 1996;81: 2653-2662.
109. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995;16:3-34.
110. Ranke MB, Elmlinger M: Functional role of insulin-like growth factor binding proteins. Horm Res 1997;48(suppl 4):9-15.
111. Li W, Fawcett J, Widmer HR, Fielder PJ, Rabkin R, Keller GA: Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. Endocrinology 1997;138:1763-1766.
112. Cohen P, Lamson G, Okajima T, Rosenfeld RG: Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth. Mol Endocrinol 1993;7:380-386.
113. Lalou C, Lassarre C, Binoux M: A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 1996;137:3206-3212.
114. Zadeh SM, Binoux M: The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology 1997;138:3069-3072.
115. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P: The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 1995;9:361-367.
116. Oh Y, Müller HL, Pham H, Rosenfeld RG: Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 1993; 268:26045-26048.
117. 1 on programmed cell death via a p53- and IGF-independent mechanism. J Biol Chem 1997;272: 12181-12188.
118. 2-induced growth inhibition in human breast cancer cells. Cancer Res 1996; 56:1545-1550.
119. Erondu NE, Dake BL, Moser DR, Lin M, Boes M, Bar RS: Regulation of endothelial IGFBP-3 synthesis and secretion by IGF-I and TGF-beta. Growth Regul 1996;6:1-9.
120. Leal SM, Liu Q, Huang SS, Huang JS: The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein-3 receptor. J Biol Chem 1997;272:20572-20576.
121. Clemmons DR, Gardner LI: A plasma factor is required for IGFBP-1 to potentiate DNA synthesis. J Cell Physiol 1990;145:129-135.
122. Elgin RG, Busby WH, Clemmons DR: An insulin-like growth factor binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 1997;84:3254-3258.
123. Koistinen R, Itkonen O, Selenius P, Seppala M: Insulin-like growth factor-binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates their DNA synthesis. Biochem Biophys Res Commun 1990; 173:408-415.
124. Clemmons DR, Cascieri MA, Camacho-Hubner C, McCusker RH, Bayne ML: Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity. J Biol Chem 1990; 265:12210-12216.
125. Jones JI, Gockerman A, Busby WH Jr, Wright G, Clemmons DR: Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha-5-beta-1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 1993;90: 10553-10557.
126. Galiano RD, Zhao LL, Clemmons DR, Roth SI, Lin X, Mustoe TA: Interaction between the IGF family and the integrin receptor family in tissue repair processes. Evidence in a rabbit ear dermal ulcer model. J Clin Invest 1996;98:2462-2468.
127. Tsuboi R, Shi CM, Sato C, Cox GN, Ogawa H: Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models. J Invest Derm 1995;104:199-203.
128. Jyung RW, Mustoe JA, Busby WH, Clemmons DR: Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1. Surgery 1994;115:133-239.
129. Clemmons DR: Role of post-translational modifications in modifying the biologic activity of insulin-like growth factor binding proteins; in LeRoith D, Raizada MK (eds): Current Directions in Insulin-Like Growth Factor Research. New York, Plenum Press, 1994, pp 245-253.
130. Lewitt MS, Saunders H, Cooney GJ, Baxter RC: Effect of human insulin-like growth factor-binding protein-1 on the half-life and action of administered insulin-like growth factor-I in rats. J Endocrinol 1993;136:253-260.
131. Bar RS, Boes M, Clemmons DR, Busby WH, Sandra A, Dake BL, Booth BA: Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology 1990;127:497-499.
132. DeMellow JSM, Baxter RC: Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 1998;156:199-204.
133. Conover CA, Powell DR: Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. Endocrinology 1991;129:710-716.
134. Hamon GA, Hunt TK, Spencer EM: In vivo effects of systemic insulin-like growth-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. Growth Regul 1993;3:55-56.
135. Clark RG, Mortensen D, Reifsynder D, Mohler M, Etcheverry T, Mukku V: Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): Effects on the glycemic and growth-promoting activities of rhIGF-I in the rat. Growth Regul 1993;3:50-52.
136. Weinzimer SA, Macarak E, Cohen P: The role of the IGF-IGFBP axis in the regulation of bladder smooth muscle growth. (in preparation).
137. Schedlich LJ, Young TF, Firth SM, Baxter RC: Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 1998;273:18347-18352.
138. Wraight CJ, Liepe IJ, Werther GA: Intracellular localisation of insulin-like growth factor binding protein-3 during mitosis in human keratinocytes; in Program and Abstracts of the 4th International Symposium on Insulin-Like Growth Factors, Tokyo, Japan. Tokyo, Foundation for Growth Science, 1997, p 139.
139. Jaques G, Noll K, Wegmann B, Witten S, Kogan E, Radulescu RT, Havemann K: Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology 1997;138:1767-1770.
140. Hodgkinson S, Fowke P, Al Somai N, McQuoid M: Proteins in tissue extracts which bind insulin-like growth factor binding protein-3 (IGFBP-3). J Endocrinol 1995;145: R1-R6.
141. Yang YWH, Yanagishita M, Rechler MM: Heparin inhibition of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human fibroblasts and rat glioma cells: Role of heparan sulfate proteoglycans. Endocrinology 1996;137:4363-4371.
142. Cohen P: Cell regulatory functions of IGFBP-3; in Program and Abstracts of the 80th Annual Meeting of The Endocrine Society, New Orleans, La). Bethesda, The Endocrine Society, 1998, p 32.
143. Xu W, Murphy LJ: Interaction of IGFBP-3 with latent transforming growth factor-β binding protein-1 identified using the yeast two-hybrid system; in Program and Abstracts of the 80th Annual Meeting of The Endocrine Society, New Orleans, La. Bethesda, The Endocrine Society, 1998, p 313.
144. Schenker T, Trueb B: Down-regulated proteins of mesenchymal tumor cells. Exp Cell Res 1998;239:161-168.
145. Reeve JG, Guadano A, Xiong J, Morgan J, Blechen NM: Diminished expression of insulin-like growth factor (IGF) binding protein-5 and activation of IGF-I-mediated autocrine growth in simian virus 40-transformed human fibroblasts. J Biol Chem 1995;270:135-142.
146. Spencer EM, Chan K: A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3. Prog Growth Factor Res 1995;6:209-214.
147. Hashimoto R, Ono M, Fujiwara H, Higashihashi N, Yoshida M, Enjoh-Kimura T, Sakano K: Binding sites and binding properties of binary and ternary complexes of insulin-like growth factor-II (IGF-II), IGF-binding protein-3, and acid-labile subunit. J Biol Chem 1997;272:27936-27942.
148. Firth SM, Ganeshprasad U, Baxter RC: Structural determinants of ligand and cell-surface binding of insulin-like-growth factor-binding protein-3. J Biol Chem 1998;273: 2631-2638.
149. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG: Synthesis and characterization of insulin-like growth factor binding protein (IGFBP-7). J Biol Chem 1996;271:30322-30325.
150. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL: Identification and
151. Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H: Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J 1994;303:591-598.
152. Akaogi K, Okabe Y, Funahashi K, Yoshitake Y, Nishikawa K, Yasunitsu H, Umeda M, Miyazaki K: Cell adhesion activity of a 30-kDa major secreted protein from human bladder carcinoma cells. Biochem Biophys Res Commun 1994;198:1046-1053.
153. Burger AM, Zhang X, Li H, Ostrowski JL, Beatty B, Venanzoni M, Papas T, Seth A: Down-regulation of TIA12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene 1998;16: 2459-2467.
154. Kim HS, Nagalla SR, Oh Y, Wilson E, Roberts CT Jr, Rosenfeld RG: Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA 1997;94:12981-12986.
155. Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991;1114:1285-1294.
156. Martinerie C, Viegas-Pequignot E, Guenard I, Dutrillaux B, Nguyen V, Bernheim A, Perbal B: Physical mapping of human loci homologous to the chicken nov proto-oncogene. Oncogene 1992;7:2529-2534.
157. Jay P, Berge-Lefranc J, Marsollier C, Mejean C, Taviaux S, Berta P: The human growth factor-inducible immediate early gene, CYR61, maps to chromosome 1p. Oncogene 1997;14: 1753-1757.
158. Zumbrunn J, Trueb B: Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett 1996;398:187-192.
159. Lassalle P, Molet S, Janin A, Heyden JV, Tavernier J, Fiers W, Devos R, Tonnel AB: ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 1996;271:20458-20464.
160. Yamanaka Y, Wilson EM, Rosenfeld RG, Oh Y: Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem 1997;272:30729-30734.
161. Vorwerk P, Yamanaka Y, Spagnoli A, Oh Y, Rosenfeld RG: Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine. J Clin Endocrinol 1998;83:1392-1395.
162. Wilson EM, Oh Y, Rosenfeld RG: Generation and characterization of an IGFBP-7 antibody: Identification of 31 kD IGFBP-7 in human biological fluids and Hs578T human breast cancer conditioned media. J Clin Endocrinol Metab 1997;82:1301-1303.
163. Hwa V, Oh Y, Burren CP, Choi WK, Graham DL, Ingermann A, Kim HS, Lopez Bermejo A, Minniti G, Pai K, Spagnoli A, Vorwerk PLV, Wanek D, Wilson EM, Yamanaka Y, Yang DY, Rosenfeld RG: IGFBP superfamily; in Rosenfeld RG, Lee PDK (eds): Proc 4th Annual DSL International Scientific Meeting. Webster, DSL Press, 1998, pp 142-153.
164. Damon SE, Haugk KL, Swisshelm K, Quinn LS: Developmental regulation of Mac25/insulin-like growth factor-binding protein-7 expression in skeletal myogenesis. Exp Cell Res 1997;237:192-195.
165. Yang DH, Kim HS, Wilson EM, Rosenfeld RG, Oh Y: Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. J Clin Endocrinol Metab 1998;83:2593-2596.
166. Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield PN, Perbal B: novH: differential expression in developing kidney and Wilm's tumors. Am J Pathol 1998;152: 1563-1575.